| Dr David Paul Tillman, DO | |
|
3850 S National Ave Ste 400, Springfield, MO 65807-5287 | |
| (417) 269-6850 | |
| (417) 269-5830 |
| Full Name | Dr David Paul Tillman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 3850 S National Ave Ste 400, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356608251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2020017667 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Centers | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 5799787784 | 195 |
News Archive
A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Noncommunicable diseases, such as heart disease and diabetes, are the leading cause of death around the world. NCDs already account for over 70 percent of deaths, with this percentage only expected to increase in the coming years.
› Verified 2 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053481689 PECOS PAC ID: 5799787784 Enrollment ID: O20070206000485 |
News Archive
A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Noncommunicable diseases, such as heart disease and diabetes, are the leading cause of death around the world. NCDs already account for over 70 percent of deaths, with this percentage only expected to increase in the coming years.
› Verified 2 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043386774 PECOS PAC ID: 5799787784 Enrollment ID: O20070213000014 |
News Archive
A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Noncommunicable diseases, such as heart disease and diabetes, are the leading cause of death around the world. NCDs already account for over 70 percent of deaths, with this percentage only expected to increase in the coming years.
› Verified 2 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902969272 PECOS PAC ID: 5799787784 Enrollment ID: O20070215000622 |
News Archive
A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Noncommunicable diseases, such as heart disease and diabetes, are the leading cause of death around the world. NCDs already account for over 70 percent of deaths, with this percentage only expected to increase in the coming years.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Paul Tillman, DO Po Box 802843, Kansas City, MO 64180-2843 Ph: (417) 269-5712 | Dr David Paul Tillman, DO 3850 S National Ave Ste 400, Springfield, MO 65807-5287 Ph: (417) 269-6850 |
News Archive
A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.
Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Noncommunicable diseases, such as heart disease and diabetes, are the leading cause of death around the world. NCDs already account for over 70 percent of deaths, with this percentage only expected to increase in the coming years.
› Verified 2 days ago
Dr. Michael P. Smith-o'brien, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1900 S National Ave, Suite 2970, Springfield, MO 65804 Phone: 417-820-3980 Fax: 417-820-3988 | |
Roy Robert Reid Iii, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5407 E Riverview St, Springfield, MO 65809 Phone: 417-827-3911 | |
Dr. Staci Dawn Rogers, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3800 S National Ave Ste 700, Springfield, MO 65807 Phone: 417-269-8817 Fax: 417-269-8744 | |
Dr. Megan Christine Rooney Thompson, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3850 S National Ave Ste 400, Springfield, MO 65807 Phone: 417-269-6850 Fax: 417-269-5830 | |
Dr. Laird A. Bell, M.D., MPH Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1423 N Jefferson Ave, #b100, Springfield, MO 65802 Phone: 417-269-8825 Fax: 417-269-8744 | |
Dr. Thomas M. Shultz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Primrose St, Suite 270, Springfield, MO 65807 Phone: 417-882-6900 Fax: 417-882-8912 | |
Dr. Andy J. Wright, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2828 N National Ave, Springfield, MO 65803 Phone: 417-837-4000 Fax: 417-875-4710 |